FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+20.9%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$38.4B
AUM Growth
+$3.99B
(+12%)
Cap. Flow
-$616M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
28.98%
Holding
520
New
61
Increased
186
Reduced
165
Closed
55
Top Buys
| 1 |
CME Group
CME
|
$217M |
| 2 |
Qualcomm
QCOM
|
$199M |
| 3 |
Appian
APPN
|
$180M |
| 4 |
DraftKings
DKNG
|
$173M |
| 5 |
Advanced Micro Devices
AMD
|
$170M |
Top Sells
| 1 |
Alibaba
BABA
|
$445M |
| 2 |
Boston Scientific
BSX
|
$340M |
| 3 |
Fidelity National Information Services
FIS
|
$297M |
| 4 |
Intercontinental Exchange
ICE
|
$229M |
| 5 |
Crown Castle
CCI
|
$210M |
Sector Composition
| 1 | Technology | 35.81% |
| 2 | Healthcare | 20.96% |
| 3 | Consumer Discretionary | 14.53% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Phreesia
PHR
$1.67B
| $885K | ﹤0.01% |
16,306
-367
| -2% | -$19.9K |
|
377
Philip Morris
PM
$251B
| $880K | ﹤0.01% |
10,631
| – | – |
|
378
Iovance Biotherapeutics
IOVA
$901M
| $873K | ﹤0.01% |
18,822
-12,485
| -40% | -$579K |
|
379
Best Buy
BBY
$16.1B
| $863K | ﹤0.01% |
8,652
-50,674
| -85% | -$5.05M |
|
|
380
Intercontinental Exchange
ICE
$99.8B
| $860K | ﹤0.01% |
7,461
-1,987,180
| -100% | -$229M |
|
381
Arvinas
ARVN
$575M
| $849K | ﹤0.01% |
+9,999
| New | +$849K |
|
382
Apellis Pharmaceuticals
APLS
$3.55B
| $847K | ﹤0.01% |
+14,811
| New | +$847K |
|
383
Gilead Sciences
GILD
$143B
| $842K | ﹤0.01% |
14,451
| – | – |
|
384
ASML
ASML
$307B
| $779K | ﹤0.01% |
1,597
-4,712
| -75% | -$2.3M |
|
385
Aptiv
APTV
$17.5B
| $765K | ﹤0.01% |
5,874
| – | – |
|
386
Hartford Financial Services
HIG
$37B
| $752K | ﹤0.01% |
15,349
| – | – |
|
|
PARA
387
DELISTED
Paramount Global Class B
PARA
| $749K | ﹤0.01% |
20,105
| – | – |
|
|
KDMN
388
DELISTED
Kadmon Holdings, Inc.
KDMN
| $746K | ﹤0.01% |
+179,825
| New | +$746K |
|
389
Accenture
ACN
$159B
| $743K | ﹤0.01% |
2,844
-251
| -8% | -$65.6K |
|
390
Prologis
PLD
$105B
| $728K | ﹤0.01% |
7,305
| – | – |
|
391
Zymeworks
ZYME
$1.14B
| $726K | ﹤0.01% |
15,370
-346
| -2% | -$16.3K |
|
392
Dow Inc
DOW
$17.4B
| $712K | ﹤0.01% |
12,828
| – | – |
|
393
Bright Horizons
BFAM
$6.64B
| $707K | ﹤0.01% |
4,085
-482,088
| -99% | -$83.4M |
|
394
C3.ai
AI
$2.15B
| $702K | ﹤0.01% |
+5,059
| New | +$702K |
|
395
Rocket Pharmaceuticals
RCKT
$354M
| $695K | ﹤0.01% |
+12,679
| New | +$695K |
|
396
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
| $679K | ﹤0.01% |
6,614
+4,484
| +211% | +$460K |
|
397
Intellia Therapeutics
NTLA
$1.29B
| $676K | ﹤0.01% |
+12,426
| New | +$676K |
|
398
MSCI
MSCI
$42.9B
| $625K | ﹤0.01% |
1,400
-45
| -3% | -$20.1K |
|
399
Progressive
PGR
$143B
| $625K | ﹤0.01% |
6,325
-1,911,816
| -100% | -$189M |
|
400
Oneok
OKE
$45.7B
| $599K | ﹤0.01% |
15,600
| – | – |
|